JOSEPH RAVID: Open Payments
NPI 1548466519 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 34 payments from 14 companies in 2025. Trend: 2023 $2,392 · 2024 $4,347 · 2025 $1,261
Food & beverage: $1,016Travel & lodging: $245
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $437 |
| Novo Nordisk Inc | 9 | $168 |
| Phathom Pharmaceuticals, Inc. | 2 | $159 |
| Sumitomo Pharma America, Inc. | 5 | $124 |
| Lilly USA, LLC | 3 | $76 |
| Astellas Pharma US Inc | 3 | $71 |
| Abbott Laboratories | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Dexcom, Inc. | 1 | $32 |
| Exact Sciences Corporation | 1 | $29 |
Products named: VOQUEZNA, GEMTESA, Ozempic, Veozah, Rybelsus, MOUNJARO, REXULTI, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
